These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 23663200)

  • 21. The progression of pathology in Parkinson's disease.
    Halliday GM; McCann H
    Ann N Y Acad Sci; 2010 Jan; 1184():188-95. PubMed ID: 20146698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microarrays in Parkinson's disease: a systematic approach.
    Miller RM; Federoff HJ
    NeuroRx; 2006 Jul; 3(3):319-26. PubMed ID: 16815215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinases and kinase signaling pathways: potential therapeutic targets in Parkinson's disease.
    Wang G; Pan J; Chen SD
    Prog Neurobiol; 2012 Aug; 98(2):207-21. PubMed ID: 22709943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heredity in Parkinson's disease: new findings.
    Lev N; Melamed E
    Isr Med Assoc J; 2001 Jun; 3(6):435-8. PubMed ID: 11433638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging roles of microglial activation and non-motor symptoms in Parkinson's disease.
    Doorn KJ; Lucassen PJ; Boddeke HW; Prins M; Berendse HW; Drukarch B; van Dam AM
    Prog Neurobiol; 2012 Aug; 98(2):222-38. PubMed ID: 22732265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computational systems biology approaches for Parkinson's disease.
    Glaab E
    Cell Tissue Res; 2018 Jul; 373(1):91-109. PubMed ID: 29185073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic contributions to Parkinson's disease.
    Huang Y; Cheung L; Rowe D; Halliday G
    Brain Res Brain Res Rev; 2004 Aug; 46(1):44-70. PubMed ID: 15297154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The conceptual framework of palliative care applied to advanced Parkinson's disease.
    Ghoche R
    Parkinsonism Relat Disord; 2012 Dec; 18 Suppl 3():S2-5. PubMed ID: 22771241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene therapy for Parkinson's disease.
    Lawlor PA; During MJ
    Expert Rev Mol Med; 2004 Mar; 6(5):1-18. PubMed ID: 15000692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrating pathways of Parkinson's disease in a molecular interaction map.
    Fujita KA; Ostaszewski M; Matsuoka Y; Ghosh S; Glaab E; Trefois C; Crespo I; Perumal TM; Jurkowski W; Antony PM; Diederich N; Buttini M; Kodama A; Satagopam VP; Eifes S; Del Sol A; Schneider R; Kitano H; Balling R
    Mol Neurobiol; 2014 Feb; 49(1):88-102. PubMed ID: 23832570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurodegenerative disorders: From clinicopathology convergence to systems biology divergence.
    Fasano M; Alberio T
    Handb Clin Neurol; 2023; 192():73-86. PubMed ID: 36796949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parkinson's disease: an update on pathogenesis and treatment.
    Foltynie T; Kahan J
    J Neurol; 2013 May; 260(5):1433-40. PubMed ID: 23589196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bilirubin and Uric Acid: Two Different Anti-oxidants in Parkinson's Disease.
    Moccia M; Pellecchia MT; Spina E; Barone P; Vitale C
    Cell Biochem Biophys; 2016 Jun; 74(2):91-2. PubMed ID: 27286855
    [No Abstract]   [Full Text] [Related]  

  • 36. Parkinson's disease.
    Kalia LV; Lang AE
    Lancet; 2015 Aug; 386(9996):896-912. PubMed ID: 25904081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical symptoms of Parkinson's disease.
    Sveinbjornsdottir S
    J Neurochem; 2016 Oct; 139 Suppl 1():318-324. PubMed ID: 27401947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parkinson's disease: a review.
    Beitz JM
    Front Biosci (Schol Ed); 2014 Jan; 6(1):65-74. PubMed ID: 24389262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Motor assessment in Parkinson`s disease.
    Opara J; Małecki A; Małecka E; Socha T
    Ann Agric Environ Med; 2017 Sep; 24(3):411-415. PubMed ID: 28954481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of Parkinson's disease.
    Tysnes OB; Storstein A
    J Neural Transm (Vienna); 2017 Aug; 124(8):901-905. PubMed ID: 28150045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.